Treatment of acute myeloblastic leukemia in adults. The GOELAM experience

Hematology and Cell Therapy

Volumn 38, Issue 5, 1996, Pages 381-391

  Harousseau, J L ^a   Pignon, B ^b   Witz, F ^c   Polin, V ^d   Tellier, Z ^d   Hurteloup, P ^d   Cahn, J Y ^e  

^a HÔTEL DIEU   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c CHU NANCY BRABOIS   (France)

^d Laboratory PHARMACIA SA   (France)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

bone marrow transplantation (allogeneic and autologous); GM CSF; leukemia (acute myeloid)

Indexed keywords

AMSACRINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDARUBICIN; MITOGUAZONE; ZORUBICIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0029807625     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0381-5     Document Type: Review

References (38)

1. Harousseau JL, Milpied N, Brière J, et al (1991) Double intensive consolidation chemotherapy in adult acute myeloid leukemia. J Clin Oncol 9:1432-1437
2. Morisson FS, Kopecky KJ, Head DR, et al (1992) Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia. Results of Southwest Oncology Group Study of Rubidazone versus Adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and Levamisole maintenance. Leukemia 6:708-714
3. Gale RP, Champlin RC (1984) How does bone marrow transplantation cure leukemia ? Lancet ii:28-30
4. Mayer RJ (1988) Allogenic transplantation versus intensive chemotherapy in first remission acute leukemia : is there a "best choice". J Clin Oncol 6:1532-1536
5. Burnett AK, Watkins R, Maharaj D et al (1984) Transplantation of unpurged autologous bone marrow in acute myeloid leukaemia in first remission. Lancet 2:1068-1070
6. Korbling M, Hunstein W, Fliedner TM et al (1989) Disease free survival after autologous bone marrow transplantation in patients with acute myeloid leukemia. Blood 74:1898-1904
7. Gorin NC, Aegerter P, Auvert B et al (1990) Autologous bone marrow transplantation for acute myeloid leukemia in first remission : a European survey of the role of the marrow purging. Blood 75:1606-1614
8. Cassileth PA, Begg CB, Silber R et al (1987) Prolonged unmaintained remission after intensive consolidation therapy in adult acute non lymphocytic leukemia. Cancer Treat Rep 71:137-140
9. Champlin R, Ho W, Winston D et al (1987) Treatment of adults with acute myelogenous leukemia : progressive evaluation of high dose cytarabine in consolidation chemotherapy and with bone marrow transplantation. Semin Oncol 14:1-6 supp 1
10. Wolff SN, Herzig RH, Fay JW et al (1989) High dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission : long term follow up and results. J Clin Oncol 7:1260-1267
11. Geiler RB, Burke PJ, Karp JE et al (1989) Two step timed sequential treatment for acute myelocytic leukemia. Blood 74:1499-1506
12. Johnson PRE, Ciu Yin JA (1993) Acute myeloid leukaemia in the elderly : biology and treatment Br J Haematol 83:2015-2019
13. Hamblin TJ (1995) Disappointements in treating acute leukemia in the elderly. N Engl J Med 332:1712-1713
14. Estey E (1994) Use of colony-stimulating factors in the treatment of acute myeloid leukemia. Blood 83:2015-2019
15. Harousseau JL, Depei Wu (1994) The use of G-CSF and GM-CSF in the treatment of acute leukemia. Leuk and Lymph 18:405-412
16. Bennet JM, Catovsky D, Daniel MT (1985) Proposed revised criteria for the classification of acute myeloid leukemia : a report of the French-American-British Cooperative Group. Ann Intern Med 103:620-625
17. Keating MJ, Smith TL, Kantarjian H et al (1988) Cytogenetic pattern in acute myelogenous leukemia : a major reproducible determinant of outcome. Leukemia 2:403-412
18. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR (1989) Prognostic impact of cytogenetic abnormalities in patients with de novo acute non lymphocytic leukemia. Blood 73:263-270
19. Buyse ME, Staquet MJ, Sylvester RJ eds (1984) Cancer clinical trials : methods and practice. Oxford, England : Oxford University Press 337-406
20. Kruskal WH, Wallis WA (1952) Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47:583-621
21. Kaplan E, Meier P (1985) Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-81
22. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc (A) 1972;135:185-206
23. Berman E, Heller G, Santorsa J et al (1991) Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood 77:1666-1682
24. Vogler WR, Velez-Garcia E, Weiner RS et al (1992) A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia : a Southeastern Cancer Study Group Study. J Clin Oncol 10:1103-1111
25. Wiernik PH, Banks PLC, Case DC et al (1992) Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood 79:313-319
26. Pignon B, Witz F, Desablens B et al (1996) Prolonged disease free survival with a unique consolidation course following induction therapy in patients with acute myelogenous leukemia aged 50 to 65 : a multicenter study of the GOELAM Group. Br J Haematol 94:333-341
27. Reiffers J, Gaspard MH, Maraninchi D et al (1989) Comparison of allogenic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission : a prospective controlled trial. Br J Haematol 72:57-63
28. Reiffers J, Stoppa AM, Attal M et al (1993) Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission : the BGMT experience. Nouv Rev Fr Hematol 35:17-19
29. Burnett AK, Goldstone AH, Stevens RF et al (1994) The role of BMT in addition to intensive chemotherapy in AML in first CR. Results of the MRC AML-10 trial. Proceed 36th ASH Annual Meeting p252a (abstract no 992).
30. Zittoun RA, Mandelli F, WillemzeR, et al (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 322:217-223
31. Mayer RJ, Davis RB, Schiffer CA et al (1994) Intensive post remission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903
32. Santos GW, Tutschka PJ, Broxmeyer R et al (1983) Marrow transplantation for acute non lymphocytic leukemia with busulfan and cyclophosphamide. N Engl J Med 309:1347-1353
33. Rowe JM, Anderson I, Mazza JJ et al (1993) Phase m randomized placebo-controlled study of granulocyte-macrophage colony stimulating factor (GM-CSF) in adult patients (55-70 years) with acute myelogenous leukemia (ANL) : a study of the Eastern Cooperative Oncology Group (ECOG). Blood 82:suppl 1 : 329a, abstract
34. Stone RM, Berg DT, George SL et al (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. N Engl J Med 332:1671-1677
35. Zittoun R, Mandelli F, De Witte T et al (1994) Recombinant human granulocyte-macrophage colony stimulating factor during induction treatment of acute myelogenous leukemia. A randomized trial from EORTOC/IMEMA Leukemia cooperative group. Blood 84(suppl 1):231a (abstract)
36. Lowenberg B, Suciu S, Zittoun R et al (1995) GM-CSF during, as well as after, induction chemotherapy in elderly patients with acute myeloid leukemia. The EORTC-HOVON phase III trial (AML II). Blood 86:suppl 1:433a (abstract)
37. Dombret H, Chastang C, Fenaux P et al (1995) A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. N Engl J Med 332:1678-1683
38. Büchner T, Hiddemann W, Rottmann R et al (1993) Multiple course chemotherapy with or without GM-CSF priming and long-term administration for newly diagnosed AML. Proceed Am Soc Clin Oncol 12:301 (abstract 985)